Challenges concerning generic substitution in hospitals
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: HåKONSEN, Helle (School of Pharmacy, University of Oslo, Oslo, Norway)
- Co-author(s): Hopen, Heidi S. (School of Pharmacy, University of Oslo, Oslo, Norway)
Toverud, Else-Lydia (School of Pharmacy, University of Oslo, Oslo, Norway)
Background The rapid growth in pharmaceutical expenditures has resulted in a wide range of cost containment strategies in secondary as well as primary health care. Although generic substitution was not legalised in Norway until 2001, generic drugs and also "synonym drugs", i.e. non-bioequivalent generic drugs, have been used interchangeably.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.